PLX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Protalix Biotherapeutics Inc

Watchlist Manager

Watchlist

Price: 2.295 USD -1.5% Market Closed

Market Cap: $184.9m

P	Protalix Biotherapeutics Inc AMEX:PLX	US
	Moncler SpA OTC:MONRF	IT
	Borgwarner Inc NYSE:BWA	US
Q	Qualigen Therapeutics Inc F:7R9B	US
E	Edison International F:EIX	US
D	Dillard's Inc F:DL7A	US
E	Ecoener SA F:89W	ES
L	LHC Group Inc F:LH6	US
	Luminar Technologies Inc F:9FS1	US
M	Melia Hotels International SA SWB:MEL	ES
	Mosaic Co NYSE:MOS	US
E	Enerpac Tool Group Corp F:PW9	US
Z	Zimmer Biomet Holdings Inc SIX:ZBH	US
	Elior Group SA OTC:ELROF	FR
	Coca-Cola Co NYSE:KO	US
A	Ascendas Real Estate Investment Trust OTC:ACDSF	SG
	Lohilo Foods AB (publ) F:66Q	SE
A	AutoCanada Inc OTC:AOCIF	CA
	Steven Madden Ltd NASDAQ:SHOO	US

Profitability Summary

Protalix Biotherapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

70%

Strong 3Y Average Gross Margin

57%

Declining Gross Margin

72% > 70%

Healthy Operating Margin

26%

Low 3Y Average Operating Margin

Operating Margin is Increasing

18% > 26%

Healthy Net Margin

20%

Low 3Y Average Net Margin

Net Margin is Increasing

13% > 20%

Exceptional Free Cash Flow Margin

17%

Negative 3Y Average Free Cash Flow Margin

-4%

Free Cash Flow Margin is Increasing

-16% > 17%

Exceptional ROE

27%

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.